The FDA rejected Pfizer (PFE)/BioNTech’s (BNTX) booster shot recommendation for the general public in order to place greater focus on inoculating the unvaccinated populations and collecting more data on booster shots, Meghan FitzGerald, adjunct associate professor of health policy and management at Columbia University, told Yahoo Finance Live.
Though the FDA rejected the booster for the general public by a large margin (16-2), the shot was endorsed unanimously for the elderly and…
Source link